Oxytocin treatment reduced food intake and body fat and ameliorated obesity in ovariectomized female rats.
Body weight
Food intake
Hypothalamus
Ovariectomy
Oxytocin
Subcutaneous fat
Visceral fat
Journal
Neuropeptides
ISSN: 1532-2785
Titre abrégé: Neuropeptides
Pays: Netherlands
ID NLM: 8103156
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
06
12
2018
revised:
05
02
2019
accepted:
10
03
2019
pubmed:
20
3
2019
medline:
18
12
2019
entrez:
20
3
2019
Statut:
ppublish
Résumé
Recent studies have shown that oxytocin reduces food intake and body weight gain and promotes lipolysis in some species, including humans. Interestingly, these effects of oxytocin are more marked in obese individuals. Although the menopausal loss of ovarian function induces increased visceral adiposity and some metabolic disorders, no safe medical interventions for these conditions have been established. In this study, we evaluated the effects of oxytocin on appetite, body weight, and fat mass in ovariectomized rats. Six-day oxytocin treatment attenuated cumulative food intake and body weight gain, and reduced visceral and subcutaneous fat weight and adipocyte cell area in ovariectomized rats. Blood examinations indicated that 6-day oxytocin treatment did not alter renal or hepatic functions. Instead, it might prevent ovariectomy-induced liver damage. In addition, acute oxytocin treatment did not affect body temperature or locomotor activity. These results indicate that oxytocin might be useful for treating or preventing menopause-induced metabolic disorders, without causing any adverse effects.
Identifiants
pubmed: 30885500
pii: S0143-4179(18)30211-7
doi: 10.1016/j.npep.2019.03.002
pii:
doi:
Substances chimiques
Oxytocin
50-56-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
49-57Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.